Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Genentech, Inc.
Scientific Title
A Phase I, Open-Label, Multicenter, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors